Cardiovascular Fixed Combination Pill ASR: Pharmacodynamic Clinical Trial of a Fixed Dose Combination of Acetylsalicylic Acid, Simvastatin, and Ramipril (Cardiovascular Polypill); LDL Cholesterol.

Trial Profile

Cardiovascular Fixed Combination Pill ASR: Pharmacodynamic Clinical Trial of a Fixed Dose Combination of Acetylsalicylic Acid, Simvastatin, and Ramipril (Cardiovascular Polypill); LDL Cholesterol.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 23 Apr 2013

At a glance

  • Drugs Aspirin/ramipril/simvastatin (Primary) ; Aspirin; Ramipril; Simvastatin
  • Indications Coronary artery disease; Hyperlipidaemia; Hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Feb 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 17 Feb 2012 Planned end date changed from 1 Jan 2012 to 1 Apr 2012 as reported by ClinicalTrials.gov.
    • 13 Jul 2011 New source identified and integrated European Clinical trials database record EudraCT2010-019720-32.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top